Veltrigen
CJC-1295 no DAC + Ipamorelin Blend
- Third-party verified · 99%+ HPLC purity
- Free shipping · Ships within 1 business day
- COA included with every batch
Specifications
| Product | CJC-1295 no DAC + Ipamorelin Blend |
|---|---|
| Quantity | 10mg per vial (5mg + 5mg) |
| Appearance | White lyophilized powder |
| Mol. Formula | |
| Storage | Store at −20°C |
| CAS Number | 863288-34-0 (CJC-1295 no DAC) / 170851-70-4 (Ipamorelin) |
For laboratory research use only. Not for human consumption, veterinary use, or clinical applications. Must be handled by qualified researchers in an appropriate facility.
About CJC-1295 no DAC + Ipamorelin Blend
CJC-1295 No DAC + Ipamorelin is a combined peptide formulation consisting of two well-studied growth hormone–related research peptides. CJC-1295 No DAC is a synthetic growth hormone–releasing hormone (GHRH) analog designed to promote short-acting, pulsatile signaling, while Ipamorelin is a selective growth hormone secretagogue receptor (GHSR) agonist studied for its specificity and minimal off-target endocrine interaction.
In laboratory research, this peptide blend is frequently utilized to explore synergistic GHRH and GHSR pathway interactions under controlled experimental conditions. Due to the absence of Drug Affinity Complex (DAC), CJC-1295 No DAC exhibits a shorter half-life, making this blend suitable for studies focused on pulsatile hormone signaling, receptor dynamics, and peptide-mediated endocrine modeling.
All Veltrigen CJC-1295 no DAC + Ipamorelin Blend is synthesized to the highest research standards, purified by preparative HPLC, and lyophilized for maximum stability and shelf life. Each vial is sealed under nitrogen.